نتایج جستجو برای: pancreas cancer

تعداد نتایج: 933379  

Journal: :JOP : Journal of the pancreas 2013
Tsukasa Nakamura Yoshio Osaka Shoichi Ishikawa Hirotaka Sako Naoaki Akamatsu Yoshihiro Yamamoto Yohei Hosokawa Norio Yoshimura

CONTEXT Lymphoepithelial cysts with sebaceous glands of the pancreas are extremely rare, with only 7 cases, including this case, published in English literature. CASE REPORT We herein present the case of a 67-year-old Asian man who underwent a resection of a lymphoepithelial cyst of the pancreas during the follow up care for lung cancer. Fourteen years previously he underwent a right lower lo...

2016
Michael Castro Koah Vierkoetter Douglas Prager Shasta Montgomery Kristin Sedgwick

BACKGROUND Synchronous cancers have occasionally been detected at initial diagnosis among patients with breast and ovarian cancer. However, simultaneous coexistence and diagnosis of breast and pancreas cancer has not previously been reported. CASE REPORT Paternal transmission of a germline BRCA2 mutation to a patient who was diagnosed at age 40 with locally advanced breast and pancreas cancer...

Journal: :Annals of clinical and laboratory science 1983
M Brandes M S Gesell H Ueda J C Millan R M Quinlan C Ernst W F Sindelar C C Kurman S Harris D Brandes

Cytoplasmic retinoic acid binding protein (cRABP) is present in human fetal pancreas and becomes nondetectable in the normal adult pancreas. The binding protein for retinoic acid becomes apparent again in pancreatic cancer. Similar fluctuations in the content of cRABP occur in the hamster. The binding protein is undetectable in the normal adult hamster pancreas, while it was detected in several...

2013
Jill P. Smith Travis E. Solomon

Smith JP, Solomon TE. Cholecystokinin and pancreatic cancer: the chicken or the egg? Am J Physiol Gastrointest Liver Physiol 306: G91–G101, 2014. First published October 31, 2013; doi:10.1152/ajpgi.00301.2013.—The gastrointestinal peptide cholecystokinin (CCK) causes the release of pancreatic digestive enzymes and growth of the normal pancreas. Exogenous CCK administration has been used in anim...

2011
Wontae Cho Yong Beom Cho Kee-Taek Jang Hee Cheol Kim Seong Hyeon Yun Woo Yong Lee Ho-Kyung Chun

Serous cystic neoplasms of the pancreas are almost always benign lesions. However, there are some case reports of malignant serous neoplasms of the pancreas. It is very difficult to distinguish malignant and benign tumors. Indeed, only clinicopathologic findings of locoregional invasion and metastasis represent a malignancy. We report a serous cystadenocarcinoma of the pancreas that was initial...

Journal: :Cirugia espanola 2014
Julio César Zevallos Quiroz Raúl Jiménez Agüero Maddi Garmendi Irizar Inmaculada Ruiz Montesinos Jhon William Comba Miranda

the pancreas: emphasis on surgical treatment. Arch Surg. 1993;128:433–6. 8. Yoon DY, Hines OJ, Bilchik AJ, Lewin K, Cortina G, Reber HA. Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure. Am Surg. 2001;67:1195–9. 9. Matsunou H, Konishi F. Papillary-cystic neoplasm of the pancreas: a clinicopathologic study concerning the tumor aging and malignancy of nine c...

2013
Tae Hee Lee Young Deok Cho Sang-Woo Cha Joo Young Cho Jae Young Jang Soung Won Jeong Hyun Jong Choi Jong Ho Moon

BACKGROUND/AIMS Endoscopic ultrasound elastography (EUS-EG) has been widely used for the evaluation of pancreatic cancer in the Western world. To date, there is very little experience with EUS-EG in Korea. We described the results of comparison between normal pancreas and pancreatic cancer in Korea. METHODS The present study was performed at a tertiary hospital on 35 subjects comprising 20 wi...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997
H A Burris M J Moore J Andersen M R Green M L Rothenberg M R Modiano M C Cripps R K Portenoy A M Storniolo P Tarassoff R Nelson F A Dorr C D Stephens D D Von Hoff

PURPOSE Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has had a significant impact on the disease. In early studies with gemcitabine, patients with pancreas cancer experienced an improvement in disease-related symptoms. Based on those findings, a definitive trial was performed to assess ...

Journal: :Journal of cellular biochemistry 2009
Hop S Tran Cao Jose Reynoso Meng Yang Hiroaki Kimura Sharmeela Kaushal Cynthia S Snyder Robert M Hoffman Michael Bouvet

A major goal for in vivo biology is to develop models which can express multiple colors of fluorescent proteins in order to image many processes simultaneously in real time. Towards this goal, the cyan fluorescent protein (CFP) nude mouse was developed by crossing non-transgenic nude mice with the transgenic CK/ECFP mouse in which the beta-actin promoter drives expression of CFP in almost all t...

Journal: :Human molecular genetics 2012
Benedikt Giessrigl Sigurd Krieger Margit Rosner Nicole Huttary Philipp Saiko Mouad Alami Samir Messaoudi Jean-François Peyrat Alexandre Maciuk Michaela Gollinger Sabine Kopf Egidijus Kazlauskas Peter Mazal Thomas Szekeres Markus Hengstschläger Daumantas Matulis Walter Jäger Georg Krupitza

Pancreas cancer cells escape most treatment options. Heat shock protein (Hsp)90 is frequently over-expressed in pancreas carcinomas and protects a number of cell-cycle regulators such as the proto-oncogene Cdc25A. We show that inhibition of Hsp90 with geldanamycin (GD) destabilizes Cdc25A independent of Chk1/2, whereas the standard drug for pancreas carcinoma treatment, gemcitabine (GEM), cause...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید